Epstein-Barr-virus antibodies in American and African Burkitt's lymphoma

Molecular epidemiology of global Candida dubliniensis isolates utilizing genomic-wide, co-dominant, PCR-based markers for strain delineation.

Medical mycology·2009

Conventional or molecular measurement of Aspergillus load.

Medical mycology·2008

Temporal expression of inflammatory mediators in brain basilar artery vasculitis and cerebrospinal fluid of rabbits with coccidioidal meningitis.

Clinical and experimental immunology·2006

Interaction between conidia, lung macrophages, immunosuppressants, proinflammatory cytokines and transcriptional regulation.

Medical mycology·2005

The contribution of animal models of aspergillosis to understanding pathogenesis, therapy and virulence.

Medical mycology·2005

Studies on itraconazole delivery and pharmacokinetics in mallard ducks (Anas platyrhynchos).

Journal of veterinary pharmacology and therapeutics·2005

8 weeks versus 12 weeks of sofosbuvir-velpatasvir for treatment-naive, non-cirrhotic, chronic hepatitis C (RESOLVE): a multicentre, open-label, non-inferiority, randomised controlled trial in India.

Lancet (London, England)·2026

Cardiovascular safety of orforglipron versus insulin glargine in adults with type 2 diabetes at increased cardiovascular risk (ACHIEVE-4): a phase 3, event-driven, randomised, open-label, non-inferiority, active comparator trial.

Lancet (London, England)·2026

A trembling detour to the diagnosis of encephalitis: a neuroborreliosis case report.

Lancet (London, England)·2026

Retatrutide in adults with obesity and type 2 diabetes (TRIUMPH-2): a double-blind, parallel-group, randomised, placebo-controlled, phase 3 trial.

Lancet (London, England)·2026

Efficacy and safety of garetosmab, an activin A-blocking antibody, in fibrodysplasia ossificans progressiva (OPTIMA): a randomised, double-blind, placebo-controlled, phase 3 trial.

Lancet (London, England)·2026

Radiotherapy versus observation following surgical resection of WHO grade 2 atypical meningioma (ROAM/EORTC-1308): an international, multicentre, open-label, phase 3, randomised controlled trial.

Lancet (London, England)·2026

High transmission risk of Human Immunodeficiency Virus in blood transfusions: A critical evaluation of blood bank serological tests in Mozambique.

PLOS global public health·2026

Evaluation of Prophylactic Negative Pressure Therapy in the Murine Hindlimb Lymphedema Model.

Journal of vascular research·2026

Evaluation of a prototype biplex VIDAS immunoassay for type-specific detection of HSV-1 and HSV-2 IgG antibodies.

Journal of clinical microbiology·2026

Mass-standardised quantitative biophotonic assay for profiling the SARS-CoV-2 spike IgG response in recovery and vaccination cohorts.

The Analyst·2026

Efgartigimod for Guillain-Barré syndrome: rationale, clinical evidence, and future perspectives.

Frontiers in immunology·2026

An LR-based risk stratification framework for assessing interlaboratory variability in HEp-2 IFA pattern interpretation.

Clinical chemistry and laboratory medicine·2026

Related Experiment Videos

Epstein-Barr-virus antibodies in American and African Burkitt's lymphoma

Related Concept Videos

Molecular epidemiology of global Candida dubliniensis isolates utilizing genomic-wide, co-dominant, PCR-based markers for strain delineation.

Conventional or molecular measurement of Aspergillus load.

Temporal expression of inflammatory mediators in brain basilar artery vasculitis and cerebrospinal fluid of rabbits with coccidioidal meningitis.

Interaction between conidia, lung macrophages, immunosuppressants, proinflammatory cytokines and transcriptional regulation.

The contribution of animal models of aspergillosis to understanding pathogenesis, therapy and virulence.

Studies on itraconazole delivery and pharmacokinetics in mallard ducks (Anas platyrhynchos).

8 weeks versus 12 weeks of sofosbuvir-velpatasvir for treatment-naive, non-cirrhotic, chronic hepatitis C (RESOLVE): a multicentre, open-label, non-inferiority, randomised controlled trial in India.

Cardiovascular safety of orforglipron versus insulin glargine in adults with type 2 diabetes at increased cardiovascular risk (ACHIEVE-4): a phase 3, event-driven, randomised, open-label, non-inferiority, active comparator trial.

A trembling detour to the diagnosis of encephalitis: a neuroborreliosis case report.

Retatrutide in adults with obesity and type 2 diabetes (TRIUMPH-2): a double-blind, parallel-group, randomised, placebo-controlled, phase 3 trial.

Efficacy and safety of garetosmab, an activin A-blocking antibody, in fibrodysplasia ossificans progressiva (OPTIMA): a randomised, double-blind, placebo-controlled, phase 3 trial.

Radiotherapy versus observation following surgical resection of WHO grade 2 atypical meningioma (ROAM/EORTC-1308): an international, multicentre, open-label, phase 3, randomised controlled trial.

High transmission risk of Human Immunodeficiency Virus in blood transfusions: A critical evaluation of blood bank serological tests in Mozambique.

Evaluation of Prophylactic Negative Pressure Therapy in the Murine Hindlimb Lymphedema Model.

Evaluation of a prototype biplex VIDAS immunoassay for type-specific detection of HSV-1 and HSV-2 IgG antibodies.

Mass-standardised quantitative biophotonic assay for profiling the SARS-CoV-2 spike IgG response in recovery and vaccination cohorts.

Efgartigimod for Guillain-Barré syndrome: rationale, clinical evidence, and future perspectives.

An LR-based risk stratification framework for assessing interlaboratory variability in HEp-2 IFA pattern interpretation.

Related Experiment Videos

Epstein-Barr-virus antibodies in American and African Burkitt's lymphoma

Related Concept Videos

Related Articles